- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 203/12 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 203/12
Total number of patents in this class: 12
10-year publication summary
|
1
|
0
|
1
|
3
|
0
|
1
|
0
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| New York Blood Center, Inc. | 169 |
3 |
| Zata Pharmaceuticals, Inc. | 13 |
2 |
| Eisai R&D Management Co., Ltd. | 1186 |
2 |
| 3m Innovative Properties Company | 17511 |
1 |
| BASF SE | 21129 |
1 |
| The Board of Trustees of the University of Illinois | 2739 |
1 |
| Immunomet Therapeutics Inc. | 31 |
1 |
| Sail Biomedicines, Inc. | 39 |
1 |
| Other owners | 0 |